#93 - Neffy Epinephrine Nasal Spray: A New Needle-Free Treatment for Anaphylaxis

Curious About Neffy, the New Nasal Epinephrine Spray?

We’re diving into everything you need to know about Neffy, the new FDA-approved nasal spray for epinephrine. This groundbreaking, needle-free option provides an easy way to manage anaphylaxis in emergencies.

Dr. Sakina Bajowala joins Dr. Gupta and Kortney to explore Neffy’s unique nasal delivery system, what distinguishes it from traditional auto-injectors, and the science behind its development. With her expertise in allergy and asthma care, Dr. Bajowala walks us through Neffy’s FDA approval journey, the technology that powers the nasal spray, and how it’s changing the landscape of allergy treatment.

What We Cover in Our Episode on Neffy Nasal Spray:

• Why Neffy Nasal Spray is Unique: Dr. Bajowala explains why nasal epinephrine is an innovative choice for anaphylaxis treatment and when it may be preferable to injectables.
• FDA Approval for Neffy: We discuss the rigorous testing behind Neffy’s FDA approval, including studies conducted with actual patients post-approval.
• Intravail Technology in Neffy Nasal Spray: Learn about the advanced technology enabling rapid, effective absorption through the nasal passages for timely intervention.
• Considerations for Using Neffy Nasal Spray: We explore practical aspects of Neffy’s use, from nasal congestion to potential side effects.
• Neffy Dosing and Side Effects: Dr. Bajowala provides insights on dosing, including when a second dose may be recommended.

Helpful links:

• Neffy: https://www.neffy.com/
• Anaphylaxis: https://allergyasthmanetwork.org/anaphylaxis/
• Epinephrine: https://allergyasthmanetwork.org/anaphylaxis/what-is-epinephrine/

This podcast is made in partnership with The Allergy & Asthma Network. Thanks to ARS Pharma for sponsoring today’s episode. While they support the show, all opinions are our own, and sponsorship doesn’t influence our content or editorial decisions. Any mention of brands is for informational purposes and not an endorsement.